Advertisement
Loading...

GRAIL, Inc.

GRALNASDAQ
Healthcare
Medical - Diagnostics & Research
$59.65
$-2.15(-3.48%)
U.S. Market opens in 37h 51m

GRAIL, Inc. Fundamental Analysis

GRAIL, Inc. (GRAL) shows moderate financial fundamentals with a PE ratio of -6.21, profit margin of -2.53%, and ROE of -16.42%. The company generates $0.2B in annual revenue with strong year-over-year growth of 17.18%.

Key Strengths

Cash Position33.95%
PEG Ratio-0.05
Current Ratio11.74

Areas of Concern

ROE-16.42%
Operating Margin-3.49%
We analyze GRAL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -170.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-170.1/100

We analyze GRAL's fundamental strength across five key dimensions:

Efficiency Score

Weak

GRAL struggles to generate sufficient returns from assets.

ROA > 10%
-14.10%

Valuation Score

Excellent

GRAL trades at attractive valuation levels.

PE < 25
-6.21
PEG Ratio < 2
-0.05

Growth Score

Excellent

GRAL delivers strong and consistent growth momentum.

Revenue Growth > 5%
17.18%
EPS Growth > 10%
82.51%

Financial Health Score

Excellent

GRAL maintains a strong and stable balance sheet.

Debt/Equity < 1
0.02
Current Ratio > 1
11.74

Profitability Score

Weak

GRAL struggles to sustain strong margins.

ROE > 15%
-1641.52%
Net Margin ≥ 15%
-2.53%
Positive Free Cash Flow
No

Key Financial Metrics

Is GRAL Expensive or Cheap?

P/E Ratio

GRAL trades at -6.21 times earnings. This suggests potential undervaluation.

-6.21

PEG Ratio

When adjusting for growth, GRAL's PEG of -0.05 indicates potential undervaluation.

-0.05

Price to Book

The market values GRAIL, Inc. at 0.98 times its book value. This may indicate undervaluation.

0.98

EV/EBITDA

Enterprise value stands at -7.24 times EBITDA. This is generally considered low.

-7.24

How Well Does GRAL Make Money?

Net Profit Margin

For every $100 in sales, GRAIL, Inc. keeps $-2.53 as profit after all expenses.

-2.53%

Operating Margin

Core operations generate -3.49 in profit for every $100 in revenue, before interest and taxes.

-3.49%

ROE

Management delivers $-16.42 in profit for every $100 of shareholder equity.

-16.42%

ROA

GRAIL, Inc. generates $-14.10 in profit for every $100 in assets, demonstrating efficient asset deployment.

-14.10%

Following the Money - Real Cash Generation

Operating Cash Flow

GRAIL, Inc. generates limited operating cash flow of $-307.28M, signaling weaker underlying cash strength.

$-307.28M

Free Cash Flow

GRAIL, Inc. generates weak or negative free cash flow of $-307.74M, restricting financial flexibility.

$-307.74M

FCF Per Share

Each share generates $-7.17 in free cash annually.

$-7.17

FCF Yield

GRAL converts -11.43% of its market value into free cash.

-11.43%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-6.21

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.05

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.98

vs 25 benchmark

P/S Ratio

Price to sales ratio

16.59

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.02

vs 25 benchmark

Current Ratio

Current assets to current liabilities

11.74

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.16

vs 25 benchmark

ROA

Return on assets percentage

-0.14

vs 25 benchmark

ROCE

Return on capital employed

-0.20

vs 25 benchmark

How GRAL Stacks Against Its Sector Peers

MetricGRAL ValueSector AveragePerformance
P/E Ratio-6.2128.62 Better (Cheaper)
ROE-16.42%783.00% Weak
Net Margin-253.22%-48181.00% (disorted) Weak
Debt/Equity0.020.39 Strong (Low Leverage)
Current Ratio11.744.12 Strong Liquidity
ROA-14.10%-21914.00% (disorted) Weak

GRAL outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews GRAIL, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-340.16%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-333.65%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ